Bello, et al.. E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR That Exerts Antitumor Activity in Multiple Preclinical Models. American Association for Cancer Research (AACR), Jan. 2011, doi:10.1158/0008-5472.can-10-2700.